Market Update – Coronavirus

Market Update – Coronavirus

Paul Niven gives an update on coronavirus and its effect on equity markets.

We have recently held an optimistic outlook on equity markets, believing they would remain supported by a reasonable growth backdrop and accommodative policy. Investors had viewed the recent dovish moves by the likes of the US Federal Reserve and the European Central Bank positively, considering the reduction of interest rates as warranting higher valuations on future earnings, despite the increased risks.

The rise and spread of Covid-19, or coronavirus as its still more commonly known, has seen risks increase, and global equities have been subject to heightened volatility as investor sentiment fluctuates between optimism around containment and fears of a full-blown global pandemic, following the accelerating rate of new infections outside China and the number of countries experiencing new cases.

The situation is fast moving and there is no certainty on whether it will become a global pandemic or if the number of cases will stabilise, peak out, and ultimately decline. However, many market participants appear to be leaning towards the former outcome. Were this to be the case, economic disruption will extend and spread, increasing recessionary risks and hitting corporate earnings. Indeed, we are already seeing companies, from banks to airlines, releasing negative announcements and cutting earnings guidance in response to the virus. In this scenario, it is likely that central banks will ease policy, but this is not a shock that is addressable through monetary action alone – we would expect both monetary and fiscal stimulus if the situation materially worsens.

At this stage, we do not think Covid-19 will tip us into a prolonged bear market, although recessionary risks have materially risen and the short-term outlook remains mired in uncertainty. Were there to be an economic downturn, we would not expect it to be overly deep or extended. While not our base case, investors should be prepared for the end of the long bull market. We are still finding plenty of opportunities and remain well placed to withstand the inevitable short-term volatility. We resolutely retain our long-term focus and believe that equity markets will continue to deliver attractive returns for the patient investor.

2
unstructured
Paul Niven
Paul Niven
Head of Asset Allocation (EMEA)
Paul Niven is Head of Asset Allocation (EMEA) at Columbia Threadneedle Investments. He is also Fund Manager for the F&C Investment Trust. Paul joined Columbia Threadneedle through the acquisition of BMO GAM (EMEA) in 2021, having previously been with BMO since 1996. He has worked in Asset Allocation and Investment Strategy since 1999, after undertaking a fund management position in Pacific Basin Equities. Paul has had responsibility for the management of Multi-Asset mandates within the group since 2002 (including large portfolios for insurance clients) and is Chair of the Investment Policy Group. He is responsible for strategic and tactical portfolio construction as well as manager selection across a variety of institutional mandates. Paul graduated from the University of Strathclyde with a BA (Hons) in Accounting and Economics, obtained an MPhil in Finance, and is a member of the UK CFA Institute.
Paul Niven

Key topics

Risk Disclaimer

The value of investments and any income derived from them can go down as well as up and investors may not get back the original amount invested.

The information, opinions, estimates or forecasts contained in this document were obtained from sources reasonably believed to be reliable and are subject to change at any time.

Team member placeholder

...

Legal and regulatory disclosures

For professional clients and/or qualified investors only

Nothing on this website is, or is intended to be, an offer, advice, or an invitation to buy or sell any investments, in any jurisdiction where, or to anyone whom it would be unlawful to do so. Please read our full terms and conditions before proceeding further with any investment product referred to on this website. This website may not be suitable for everyone, and if you are at all unsure whether an investment product referenced on this website will meet your individual needs, please seek professional advice before proceeding further with such product. I have read and accept the terms and conditions and cookie policy of this site.